The efficacy and tolerability of levetiracetam in pharmacoresistant epileptic dogs

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

Berkley A. Lynch, Nathalie Lambeng, Karl Nocka et al. · Proceedings of the National Academy of Sciences · 2004 · 1.6K citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Proposal for a New Classification of Outcome with Respect to Epileptic Seizures Following Epilepsy Surgery

Heinz Gregor Wieser, Warren T. Blume, D. R. Fish et al. · Epilepsia · 2001 · 881 citations

Medicine, Neurosurgery, Surgery +13

Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy

Henrik Klitgaard, Alain Matagne, J.G. Gobert et al. · European Journal of Pharmacology · 1998 · 509 citations

Medicine, Neuroscience, Pharmacology +12

Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy

Martin J. Brodie, Emilio Perucca, Philippe Ryvlin et al. · Neurology · 2007 · 465 citations

Medicine, Pharmacology, Pharmacotherapy +14

Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)

Kelly M. Crowder, Jane M. Gunther, Theresa A. Jones et al. · Proceedings of the National Academy of Sciences · 1999 · 415 citations

Life Sciences, Neurobiology, Neuroscience +17